Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katzenstein

Showing results (801-810 of 874) with videos related to

Pageof 88
Sort By:
Pediatric Blood & Cancer|June 15, 2011
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) studyHeidi V Russell, Susan G Groshen, Tasnim Ara, et al.
The Journal of Infectious Diseases|December 26, 2001
Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapyJ L Lathey, C Tierney, S Y Chang, et al.
The Journal of Infectious Diseases|September 2, 2005
Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapineEsther J Lee, Rami Kantor, Lynn Zijenah, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 22, 2026
Steatotic liver disease, clinical subtypes and adverse perinatal outcomes: the prospective Fatty Liver in Pregnancy StudyTatyana Kushner, Rachel Meislin, Cecilia Katzenstein, et al.
AIDS (London, England)|March 24, 2012
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settingsJohn A Bartlett, Heather J Ribaudo, Carole L Wallis, et al.
Viruses|January 21, 2023
Insights into HIV-1 Transmission Dynamics Using Routinely Collected Data in the Mid-Atlantic United StatesSeble G Kassaye, Zehava Grossman, Priyanka Vengurlekar, et al.
Journal of Virology|March 16, 2004
Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral loadAgatha Masemola, Tumelo Mashishi, Greg Khoury, et al.
JAMA|July 11, 1998
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA PanelC C Carpenter, M A Fischl, S M Hammer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortiumTanya M Trippett, Cynthia Herzog, James A Whitlock, et al.
AIDS Research and Human Retroviruses|May 3, 2013
Therapeutic vaccination using cationic liposome-adjuvanted HIV type 1 peptides representing HLA-supertype-restricted subdominant T cell epitopes: safety, immunogenicity, and feasibility in Guinea-BissauVictor Raúl Gómez Román, Kristoffer Jarlov Jensen, Sanne Skov Jensen, et al.
Pageof 88

Showing results (801-810 of 874) with videos related to

Sort By:
Pageof 88
Pediatric Blood & Cancer|June 15, 2011
A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: a new approaches to neuroblastoma therapy (NANT) studyHeidi V Russell, Susan G Groshen, Tasnim Ara, et al.
The Journal of Infectious Diseases|December 26, 2001
Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapyJ L Lathey, C Tierney, S Y Chang, et al.
The Journal of Infectious Diseases|September 2, 2005
Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapineEsther J Lee, Rami Kantor, Lynn Zijenah, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 22, 2026
Steatotic liver disease, clinical subtypes and adverse perinatal outcomes: the prospective Fatty Liver in Pregnancy StudyTatyana Kushner, Rachel Meislin, Cecilia Katzenstein, et al.
AIDS (London, England)|March 24, 2012
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settingsJohn A Bartlett, Heather J Ribaudo, Carole L Wallis, et al.
Viruses|January 21, 2023
Insights into HIV-1 Transmission Dynamics Using Routinely Collected Data in the Mid-Atlantic United StatesSeble G Kassaye, Zehava Grossman, Priyanka Vengurlekar, et al.
Journal of Virology|March 16, 2004
Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral loadAgatha Masemola, Tumelo Mashishi, Greg Khoury, et al.
JAMA|July 11, 1998
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA PanelC C Carpenter, M A Fischl, S M Hammer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortiumTanya M Trippett, Cynthia Herzog, James A Whitlock, et al.
AIDS Research and Human Retroviruses|May 3, 2013
Therapeutic vaccination using cationic liposome-adjuvanted HIV type 1 peptides representing HLA-supertype-restricted subdominant T cell epitopes: safety, immunogenicity, and feasibility in Guinea-BissauVictor Raúl Gómez Román, Kristoffer Jarlov Jensen, Sanne Skov Jensen, et al.
Pageof 88